Table 2.
Multiple linear regression analyses for mean grant and maximum grant relative citation ratios.
| Mean grant relative citation ratioa | Maximum grant relative citation ratiob | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||
| β | P value | [95% confidence interval] | β | P value | [95% confidence interval] | |||
| Recruitment policy1 | 1.984 | 0.005** | 1.232 | 3.196 | 1.581 | 0.246 | 0.726 | 3.440 |
| Grantee size2 | ||||||||
| x < $200,000,000USD | REF | REF | REF | REF | REF | REF | REF | REF |
| $200,000,000USD ≤ x < $400,000,000 | 1.000 | 0.998 | 0.767 | 1.304 | 1.051 | 0.821 | 0.682 | 1.618 |
| x ≥ $400,000,000USD | 0.884 | 0.340 | 0.686 | 1.140 | 0.909 | 0.650 | 0.601 | 1.376 |
| Total award cost | 1.000 | 0.361 | 1.000 | 1.000 | 1.000 | 0.403 | 1.000 | 1.000 |
| Planned sample size | 1.000 | 0.360 | 1.000 | 1.000 | 1.000 | 0.896 | 1.000 | 1.000 |
| Fiscal year | 0.738 | 0.006** | 0.595 | 0.917 | 0.753 | 0.114 | 0.529 | 1.072 |
| Funding mechanism3 | ||||||||
| R01 | REF | REF | REF | REF | REF | REF | REF | REF |
| K (Career development) | 1.625 | 0.203 | 0.767 | 3.442 | 2.665 | 0.115 | 0.784 | 9.063 |
| R15 | 0.843 | 0.698 | 0.353 | 2.014 | 0.443 | 0.258 | 0.107 | 1.831 |
| R21 | 0.471 | 0.206 | 0.146 | 1.522 | 0.257 | 0.162 | 0.038 | 1.740 |
| R34 | 1.667 | 0.053 | 0.993 | 2.799 | 0.867 | 0.739 | 0.373 | 2.019 |
| R43 | 0.158 | 0.002** | 0.049 | 0.512 | 0.061 | 0.005** | 0.009 | 0.414 |
| U01 | 1.208 | 0.290 | 0.849 | 1.720 | 0.890 | 0.689 | 0.500 | 1.582 |
| U10 | 0.564 | 0.104 | 0.282 | 1.127 | 0.777 | 0.659 | 0.251 | 2.402 |
| Clinical trial design | ||||||||
| RCT3 | REF | REF | REF | REF | REF | REF | REF | REF |
| Cluster RCT4 | 0.831 | 0.441 | 0.518 | 1.334 | 0.807 | 0.584 | 0.373 | 1.746 |
| Pre/post trial | 0.583 | 0.229 | 0.241 | 1.410 | 0.292 | 0.093 | 0.069 | 1.233 |
Mean Relative Citation Ratio of all publications for each grant
Highest Relative Citation Ratio of any publication for each grant
NIMH Recruitment Milestone Reporting Policy;
Grantee’s total NIH funding in FY2006;
Individually-randomized control trial;
Cluster-randomized control trial.
:0.001 ≤ P ≤ 0.01